Open AccessA retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma
Author(s) -
Peng Liu,
Ying Han,
Shiyu Jiang,
Xiaohong He,
Yan Qin,
Lin Gui,
Shengyu Zhou,
Liqun Zhou,
Jian Yang,
Sheng Yang,
Tingyu Wen,
Yuankai Shi
Publication year - 2019
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000000354
Subject(s) - medicine , diffuse large b cell lymphoma , rituximab , retrospective cohort study , lymphoma , medical record , cancer , survival rate
Elderly patients with diffuse large B-cell lymphoma (DLBCL) have a worse prognosis than younger patients, and the optimal treatment strategy for this group remains controversial. We conducted a retrospective analysis to investigate the clinical features and outcomes of elderly patients (>60 years) and to assess the impact of clinical and molecular factors on outcome in this age group.